NanoViricides, Inc.
NNVC
$1.13
-$0.01-0.88%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.17% | 14.04% | -14.14% | -2.30% | -0.09% |
| Total Depreciation and Amortization | -19.93% | -11.04% | -2.00% | 2.11% | 2.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.59% | 0.95% | 0.54% | -42.34% | -44.21% |
| Change in Net Operating Assets | -96.50% | -133.55% | -97.95% | -76.65% | -92.05% |
| Cash from Operations | 10.65% | 3.37% | -34.25% | -30.40% | -34.00% |
| Capital Expenditure | 50.16% | 51.56% | 63.60% | -137.70% | -150.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 50.16% | 51.56% | 63.60% | -137.70% | -150.46% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.24% | 0.03% | 69.76% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.24% | 0.03% | 69.76% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 192.64% | 11.69% | 3.37% | 88.82% | 79.25% |